Page last updated: 2024-08-17

carbostyril and Kidney Neoplasms

carbostyril has been researched along with Kidney Neoplasms in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.67)29.6817
2010's14 (93.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjarnason, GA; Edeline, J; Escudier, B; Faivre, S; Fartoux, L; Germann, N; Hirte, H; Jones, R; Mackay, H; Oza, A; Plummer, R; Pouget, JC; Thistlethwaite, F; Van Cutsem, E; Vergote, I1
Schmidinger, M1
Bjarnason, GA; Cai, C; Davis, ID; De Giorgi, U; Escudier, B; Esteban, E; Grünwald, V; Kollmannsberger, C; Lee, JL; Marker, M; Melichar, B; Motzer, RJ; Porta, C; Rha, SY; Shi, MM; Squires, M; Sternberg, CN; Szczylik, C; Urbanowitz, G; Vogelzang, NJ; Zolnierek, J1
Payton, S1
Angevin, E; Beall, S; Castellano, D; Escudier, B; Grünwald, V; Gschwend, JE; Harzstark, A; Lin, CC; Ou, YC; Pirotta, N; Ravaud, A; Shi, M; Squires, M1
Chowdhury, S; Crabb, S; Davies, R; Foreshaw, A; Foreshew, SJ; Galazi, M; Greenwood, M; Jones, R; Lim, L; Nixon, J; Pacey, S; Powles, T; Pungaliya, A; Sahdev, A; Sarwar, N; Shamash, J; Wilson, P1
Balar, AV; Bangalore, S; Kang, SK; Ohmann, EL; Volodarskiy, A1
Albiges, L; Bensalah, K; Bex, A; Canfield, SE; Dabestani, S; Fernández-Pello, S; Giles, RH; Hofmann, F; Hora, M; Kuczyk, MA; Lam, TB; Ljungberg, B; Marconi, L; Merseburger, AS; Powles, T; Staehler, M; Tahbaz, R; Volpe, A1
Cohen, PR; Diwan, AH; Evans, HL; Hong, DS; Kurzrock, R; Prieto, VG; Reddy, SB; Tannir, NM; Wright, JJ1
Angevin, E; Escudier, B; Lambotte, O; Loriot, Y; Massard, C; Soria, JC1
Bernhard, JC; De Clermont, H; Gross-Goupil, M; Quivy, A; Ravaud, A; Roca, S1
Rexer, H1
Bentley, DR; Brugarolas, J; Cadeddu, JA; Gillen, J; Kabbani, W; Kapur, P; Kucejova, B; Lotan, Y; Margulis, V; McBride, DJ; Morlock, L; Pavia-Jimenez, A; Peña-Llopis, S; Raj, GV; Ross, MT; Sagalowsky, A; Sivanand, S; Spence, P; Williams, NS; Wolff, NC; Xie, XJ; Yamasaki, T; Zhao, H1
Beuselinck, B; Blesius, A; Chevreau, C; Escudier, B; Oudard, S; Ravaud, A; Rolland, F1
Angevin, E; Castellano, D; Chang, J; Escudier, B; Gschwend, JE; Harzstark, A; Kay, A; Lin, CC; Lopez-Martin, JA; Sen, P; Shi, M; Soria, JC1

Reviews

2 review(s) available for carbostyril and Kidney Neoplasms

ArticleYear
Efficacy and Safety of Selective Vascular Endothelial Growth Factor Receptor Inhibitors Compared with Sorafenib for Metastatic Renal Cell Carcinoma: a Meta-analysis of Randomised Controlled Trials.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2016, Volume: 28, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Axitinib; Benzimidazoles; Carcinoma, Renal Cell; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Niacinamide; Phenylurea Compounds; Prognosis; Quinolines; Quinolones; Randomized Controlled Trials as Topic; Sorafenib; Survival Rate; Vascular Endothelial Growth Factor A

2016
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma.
    European urology, 2017, Volume: 71, Issue:3

    Topics: Anilides; Antineoplastic Agents; Axitinib; Benzimidazoles; Bevacizumab; Carcinoma, Renal Cell; Comparative Effectiveness Research; Disease-Free Survival; Erlotinib Hydrochloride; Everolimus; Humans; Imidazoles; Indazoles; Indoles; Interferons; Interleukin-2; Kidney Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Pyrimidines; Pyrroles; Pyrrolidinones; Quinolines; Quinolones; Sirolimus; Sorafenib; Sulfonamides; Sunitinib

2017

Trials

7 trial(s) available for carbostyril and Kidney Neoplasms

ArticleYear
A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers.
    Targeted oncology, 2017, Volume: 12, Issue:5

    Topics: Antineoplastic Agents; Carcinoma; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Liver Neoplasms; Male; Ovarian Neoplasms; Quinolones; Stomach Neoplasms

2017
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.
    The Lancet. Oncology, 2014, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzimidazoles; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Quinolones; Sorafenib; Vascular Endothelial Growth Factor A

2014
Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jun-01, Volume: 20, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzimidazoles; Carcinoma, Renal Cell; Disease-Free Survival; Female; Fibroblast Growth Factor-23; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Quinolones; Receptors, Vascular Endothelial Growth Factor; Salvage Therapy

2014
A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancer.
    European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Renal Cell; Cohort Studies; Disease-Free Survival; Dose-Response Relationship, Drug; Everolimus; Fatigue; Female; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Quinolones; Sirolimus

2014
[Third-line therapy for metastasized renal cell carcinoma: a randomized, multicenter non-blinded phase III study to compare safety and effectiveness of TF1258 versus sorafenib in patients with metastasized renal cell carcinoma following failure of antiang
    Der Urologe. Ausg. A, 2011, Volume: 50, Issue:10

    Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Benzenesulfonates; Benzimidazoles; Carcinoma, Renal Cell; Disease Progression; Female; Germany; Humans; Kidney Neoplasms; Male; Molecular Targeted Therapy; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Pyridines; Quinolones; Sorafenib; Survival Rate; TOR Serine-Threonine Kinases; Treatment Failure; Vascular Endothelial Growth Factor A

2011
Are tyrosine kinase inhibitors still active in patients with metastatic renal cell carcinoma previously treated with a tyrosine kinase inhibitor and everolimus? Experience of 36 patients treated in France in the RECORD-1 Trial.
    Clinical genitourinary cancer, 2013, Volume: 11, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Benzimidazoles; Carcinoma, Renal Cell; Disease-Free Survival; Everolimus; Female; France; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles; Quinolones; Salvage Therapy; Sirolimus; Sorafenib; Sunitinib; TOR Serine-Threonine Kinases; Treatment Failure; Treatment Outcome

2013
Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Mar-01, Volume: 19, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Renal Cell; Drug Evaluation, Preclinical; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Maximum Tolerated Dose; Mice; Mice, Nude; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Platelet-Derived Growth Factor beta; Sorafenib; Survival Rate; Tissue Distribution; Vascular Endothelial Growth Factor Receptor-1

2013

Other Studies

6 other study(ies) available for carbostyril and Kidney Neoplasms

ArticleYear
Third-line dovitinib in metastatic renal cell carcinoma.
    The Lancet. Oncology, 2014, Volume: 15, Issue:3

    Topics: Antineoplastic Agents; Benzimidazoles; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Quinolones; Sorafenib

2014
Kidney cancer: targeting FGF for third-line treatment of mRCC.
    Nature reviews. Urology, 2014, Volume: 11, Issue:4

    Topics: Antineoplastic Agents; Benzimidazoles; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Quinolones

2014
Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib.
    Archives of dermatology, 2008, Volume: 144, Issue:6

    Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Biopsy; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Quinolones; Receptors, Vascular Endothelial Growth Factor; Skin Neoplasms; Sorafenib

2008
FGFR inhibitor induced peripheral neuropathy in patients with advanced RCC.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:7

    Topics: Benzimidazoles; Carcinoma, Renal Cell; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; ErbB Receptors; Humans; Kidney Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome

2010
Efficacy of re-challenging metastatic renal cell carcinoma with mTOR inhibitors.
    Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:7

    Topics: Antineoplastic Agents; Benzimidazoles; Carcinoma, Renal Cell; Everolimus; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pyrroles; Quinolones; Sirolimus; Sunitinib; TOR Serine-Threonine Kinases

2011
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma.
    Science translational medicine, 2012, Jun-06, Volume: 4, Issue:137

    Topics: Adult; Aged; Aged, 80 and over; Animals; Benzimidazoles; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Mice; Middle Aged; Quinolones; Xenograft Model Antitumor Assays

2012